Related Experiment Videos
Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis
B Dubois1, G Opdenakker, H Carton
1Rega Institute for Medical Research, Leuven, Belgium.
Acta Neurologica Belgica
|April 28, 1999
Summary
Matrix metalloproteases (MMPs) play a role in the central nervous system by breaking down proteins. Dysregulation of MMPs may contribute to autoimmune diseases like multiple sclerosis via the REGA model.
Area of Science:
- Neuroscience
- Biochemistry
- Immunology
Background:
- Matrix metalloproteases (MMPs) are enzymes involved in physiological and pathological processes.
- In the central nervous system, MMPs degrade extracellular matrix, myelin, and other components, potentially increasing antigenic epitopes.
Purpose of the Study:
- To explain the REGA (Remnant Epitopes Generate Autoimmunity) model for autoimmune disease pathophysiology.
- To review the regulation of MMP activity and its role in disease.
Main Methods:
- Discussion of MMP regulation at transcriptional, secretion, activation, and inhibition levels.
- Focus on Gelatinase B as a prototypic MMP example.
Main Results:
- MMP activity is tightly controlled through multiple mechanisms.
- The REGA model proposes how MMP-mediated degradation can trigger autoimmunity.
Conclusions:
- Understanding MMP regulation is crucial for developing therapeutic strategies for autoimmune diseases.
- MMPs are implicated in the pathogenesis of conditions like multiple sclerosis.